Lansforsakringar Fondforvaltning AB publ Invests $7.05 Million in Globe Life Inc. $GL

Lansforsakringar Fondforvaltning AB publ acquired a new stake in shares of Globe Life Inc. (NYSE:GL) in the 1st quarter, HoldingsChannel.com reports. The firm acquired 50,684 shares of the company’s stock, valued at approximately $7,054,000.

Other institutional investors have also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Globe Life by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after buying an additional 607 shares in the last quarter. NewEdge Advisors LLC boosted its holdings in Globe Life by 368.1% in the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock worth $897,000 after acquiring an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Globe Life by 11.5% during the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock worth $74,161,000 after acquiring an additional 58,163 shares during the last quarter. Empowered Funds LLC purchased a new stake in shares of Globe Life during the first quarter worth about $428,000. Finally, Focus Partners Wealth increased its holdings in shares of Globe Life by 8.3% during the first quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after acquiring an additional 656 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently commented on GL shares. Truist Financial increased their price objective on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. Texas Capital raised shares of Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. TD Cowen raised their price target on shares of Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a report on Tuesday, June 23rd. Finally, Morgan Stanley lifted their price objective on shares of Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, May 21st. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $175.89.

Globe Life Stock Up 0.2%

Shares of GL stock opened at $180.47 on Friday. Globe Life Inc. has a fifty-two week low of $116.73 and a fifty-two week high of $182.32. The firm has a market capitalization of $14.01 billion, a PE ratio of 12.48 and a beta of 0.47. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The stock’s 50-day simple moving average is $160.62 and its 200-day simple moving average is $148.63.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The firm had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period last year, the firm earned $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Equities analysts expect that Globe Life Inc. will post 15.64 earnings per share for the current year.

Globe Life Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a yield of 0.7%. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Insider Buying and Selling at Globe Life

In other news, Director Cheryl Alston sold 8,258 shares of the stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the sale, the director owned 16,621 shares in the company, valued at $2,979,148.04. This represents a 33.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Frank M. Svoboda sold 10,000 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the transaction, the chief executive officer directly owned 54,020 shares of the company’s stock, valued at approximately $9,004,053.60. This trade represents a 15.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 124,187 shares of company stock worth $19,529,414. Corporate insiders own 2.11% of the company’s stock.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.